Alfa Labs INC

Alfa Labs INC was paid $416K by Medicaid between Oct 2020 and Dec 2024, across 27 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 87% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in North Carolina

Rank by total paid#55 of 128

Median peer was paid$268K

This provider vs. median1.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	2,227	$7K
2021	4,457	$320K
2022	3,743	$24K
2023	887	$7K
2024incomplete	490	$57K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	87%	3,139	903	$362K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.1%	564	252	$21K
80346		1.3%	408	162	$5K
80362		1.1%	764	190	$5K
80325		<1%	257	109	$3K
80372		<1%	415	164	$2K
80365		<1%	435	178	$2K
80336		<1%	415	164	$1K
80369		<1%	325	147	$1K
80373		<1%	417	164	$1K
80367		<1%	412	164	$1K
80354		<1%	307	135	$942.48

15 more codes

80349		<1%	256	$906.90
80361		<1%	303	$896.41
80375		<1%	285	$841.40
80358		<1%	281	$805.70
80344		<1%	322	$801.83
80356		<1%	259	$693.09
80332		<1%	259	$673.00
80323		<1%	258	$662.60
80371		<1%	258	$662.60
80366		<1%	256	$652.20
80359		<1%	260	$642.00
80353		<1%	258	$622.46
80345		<1%	258	$489.24
81002		<1%	239	$430.82
82570		<1%	194	$146.51

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANBALAGAN, VICTOR (OWNER/DIRECTOR)